CN103202940A - Antiphlogistic drug - Google Patents

Antiphlogistic drug Download PDF

Info

Publication number
CN103202940A
CN103202940A CN2013100334351A CN201310033435A CN103202940A CN 103202940 A CN103202940 A CN 103202940A CN 2013100334351 A CN2013100334351 A CN 2013100334351A CN 201310033435 A CN201310033435 A CN 201310033435A CN 103202940 A CN103202940 A CN 103202940A
Authority
CN
China
Prior art keywords
bulbus allii
juice
cyclamate
antiphlogistic drug
antiphlogistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100334351A
Other languages
Chinese (zh)
Inventor
袁清洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013100334351A priority Critical patent/CN103202940A/en
Publication of CN103202940A publication Critical patent/CN103202940A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to an antiphlogistic drug and a preparation method thereof, specifically to an antiphlogistic drug. The antiphlogistic drug is prepared from white vinegar, garlic juice, pure honey, edible alcohol and sodium cyclamate in a weight ratio. According to the invention, since the vinegar, the garlic juice, the pure honey, the edible alcohol and the sodium cyclamate are blended together, advantages of the above-mentioned components mutually complement, antiphlogistic effects are enhanced, volatilization of a decoction of the components is reduced, sour taste and pungent taste are neutralized, and the orally-takable, externally-applicable and multifunctional antiphlogistic drug with a good curative effect can be prepared. The antiphlogistic drug provided by the invention has substantial curative effects on beriberi, eczema, skin itch, pharyngitis, chronic pharyngitis, stomatitis, enterogastritis, colds, sores in a mouth and on a tongue, dysentery, skin cancers, other skin diseases and digestive and respiratory diseases. The preparation method for the antiphlogistic drug has the advantages of easiness, easily available raw materials, low production cost and easy realization of mass production.

Description

A kind of anti-inflammation drugs
Technical field
The present invention relates to a kind of antibiotic medicine and preparation method thereof, particularly a kind of anti-inflammation drugs.
Background technology
The inflammation of skin, respiratory system and digestive system aspect is common disease in the life.
Dermatosis usually is subjected to the influence of factors such as heredity, occupation, seasonal variations, age, weather, region, endocrine and produces, as is easy to take place beriberi that fungal infection produces, tinea pedis etc. in the skin pruritus, the summer that are easy to occur senectitude.The nearly kind more than 1000 of dermatosis, and a lot of dermatosiss are outward manifestations of viscera disease, slight scytitis causes the difficult peace of patient's sleeping and eating, influence its daily life, comparatively Wan Gu dermatosis might be also can be unbalance with toxin, organism metabolic disorder, the immunologic function of pathogenic microorganism infection and generation thereof, endocrine regulation, free radical toxin dysbolismus, even have indirectly with spirit, neural pathological change or direct relation.
Fast development along with urbanization process, be subjected to the influence of factors such as atmospheric pollution, smoking, contact with external environment that its sickness rate of respiratory system disease is more and more higher the most frequently, the lighter is as heating, laryngopharynx swelling and pain etc., mostly be that cough, chest pain, breathing are influenced, weight person's dyspnea, anoxia, even respiratory failure and causing death.And because the influence of factors such as social development is rapid, the work life stress is big, psychentonia, digestive system disease such as gastric ulcer, acute or chronic gastritis, stomachaches etc. in recent years have the trend that is tending towards rejuvenation especially, as not obtaining radical cure in time, chronic inflammatory disease easily repeatedly, become the chronic disease that does not heal for many years, even the possibility that causes canceration is arranged, cause serious consequence.
The treatment scytitis is commonly based on antipruritic, antibiotic externally-applied ointment, emulsifiable paste or disinfectant preparation, disclosing a kind of as Chinese patent ZL200810304568.7 is active component with Radix Et Rhizoma Rhei, sulfur, Rhizoma Curcumae Longae, Borneolum Syntheticum etc., has preparation for external application to skin and the method for making of antiinflammatory, antipruritic and disinfection effect.Breathe and mostly the treatment of digestive system disease is that the composition of analgesic by having, antibiotic, analgesia, antiinflammatory, antiviral efficacy is preparations such as main oral liquid or Chinese patent medicine, as Chinese patent ZL03101328.7 disclose a kind of by in the tradition, Tibetan medicine: the refining treatment gastric ulcers that form such as Rhizoma Seu Herba Bergeniae, Rhizoma Alpiniae Officinarum, the oral drugs of digestive system disease such as acute and chronic gastritis; Chinese patent ZL200710132670.9 then discloses a kind of pharmaceutical composition that contains Hesperidin extract, baicalin extract, puerarin extract and belamcandin extract for the treatment of respiratory system infection and preparation method thereof; Chinese patent ZL96100527.0 disclose a kind of with Radix seu Herba Spiranthis Lanceae, JIUYUE give birth to etc. the section of Six-element medical material, dry, pulverize the back according to the processing technology of routine be made antibiotic, antiinflammatory, hemostasis capsule, mainly can treat the disease of digestive system, respiratory system, urinary system, as gastritis, tracheitis, pneumonia, pulmonary heart disease, otitis media, stomatitis, pericarditis, cervicitis, arthritis etc.
Existing above-mentioned anti-inflammation drugs comes with some shortcomings, and as bigger based on the medicinal herb components abnormal smells from the patient in its prescription of Perorally administrable antimicrobial antibiotic medicine of medicinal herb components, some patients can not adapt to; And Chinese medicine ingredients is that master's medicine is comparatively complicated to the extraction of active ingredients of Chinese herbal medicine in its preparation process, and manufacturing process is loaded down with trivial details consuming time; The anti-inflammation formulation of the mixing of part Chinese medicine and western medicine or Western medicine, except multiple antiinflammatory, antiviral effective Chinese medicine and the antibiotic Western medicine of spectrum are carried out compatibility, also add hormone, chemical constituent, wherein the existence of hormone can bring certain side effect, and some chemical constituents also can be brought negative effect to human body.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, provide that a kind of compound method is easy, raw material easily obtains, cost is low, both oral administrations, can be coated with outward again, multi-functional, high curative effect, be used for the treatment of beriberi, eczema, skin pruritus, pharyngitis, chronic pharyngitis, stomatitis, gastroenteritis, flu, aphtha of the mouth and tongue, dysentery, skin carcinoma and other dermopathic antibiotic medicine and preparation method thereof.
For addressing the above problem, the technical solution adopted in the present invention is: a kind of anti-inflammation drugs, composed of the following components:
The mass fraction of respectively forming component of described anti-inflammation drugs is: white vinegar 60-80%, Bulbus Allii juice 5-15%, pure Mel 10-15%, edible ethanol 3-10%, cyclamate 0.05-0.2%.
The preparation method of described anti-inflammation drugs comprises following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) press mass fraction: white vinegar 60-80%, the ratio of Bulbus Allii juice 5-15%, pure Mel 10-15%, edible ethanol 3-10%, cyclamate 0.05-0.2%, earlier in Bulbus Allii juice, add edible ethanol, stir, seal 1 ~ 4 hour, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(3) set by step after (2) finish bottling, 100 ℃ ~ high temperature steaming sterilization 1 ~ 2 hour more than 200 ℃.
Its mechanism of action of anti-inflammation drugs of the present invention is as follows: Bulbus Allii juice acrid in the mouth warm in nature is peppery, contained garlicin has very strong bactericidal action, for bacillary, the sexy infectious diseases of fungoid and protozoon has tangible preventive and therapeutic action, and diseases such as cancer, cold, asthma, measles are had splendid therapeutic effect; The Main Ingredients and Appearance of white vinegar is acetic acid, also contains lactic acid, Fructus Vitis viniferae acid, succinic acid, aminoacid, glycerol etc. in addition, and vinegar has very strong bactericidal action, and scientist finds also have cancer-resisting substance in the vinegar both at home and abroad recently; The Main Ingredients and Appearance of pure Mel is fructose, glucose, vitamin, aminoacid, trace element and bioactive enzyme material, Mel has defending and fighting against diseases, enhances metabolism, promote the effect of tissue regeneration, gastroenteropathy, respiratory tract disease and hepatic disease are had tangible curative effect; Edible ethanol has the effect of invading medicine and the effect of disinfection; Cyclamate is high sweet substance, can in and the acid gas of vinegar and the acid of Bulbus Allii juice.The present invention allocates vinegar, Bulbus Allii juice, pure Mel, edible ethanol, cyclamate together, can play mutual supplement with each other's advantages, strengthens anti-inflammatory effect, reduce the medicine juice volatilization, in and tart flavour and acid, make it to become both oral administrations, can be coated with the antibiotic medicine of multi-functional, high curative effect again outward.
The effect of anti-inflammation drugs of the present invention and effect: anti-inflammation drugs of the present invention has significant curative effect to beriberi, eczema, skin pruritus, pharyngitis, chronic pharyngitis, stomatitis, gastroenteritis, flu, aphtha of the mouth and tongue, dysentery, skin carcinoma and other dermatosis.Anti-inflammation drugs of the present invention was cured flu, dysentery, gastroenteritis in general one day, to beriberi, eczema, pharyngitis, chronic pharyngitis, stomatitis, aphtha of the mouth and tongue, generally once took effect, and a week cures.
The usage and dosage of anti-inflammation drugs of the present invention:
(1) be used for the treatment of dermatosis: be stained with full anti-inflammation drugs with cotton balls or cotton stalk and spread upon the affected part, every day is more than six times, if the treatment skin carcinoma then is stained with full anti-inflammation drugs with cotton cloth and is attached to the affected part, wrap up with dry gauze the outside, changed dressings once in per 12 hours; The treatment dermatosis is preferably for oral administration outer to be coated with that to carry out effect simultaneously better;
(2) be used for the treatment of digestive system and respiratory tract system disease: the method that adopts buccal or oral anti-inflammatory drug thing.To it be added in pure water or the cold boiled water in the ratio of anti-inflammation drugs and pure water or cold boiled water 1:3 before buccal or the oral anti-inflammatory drug thing, shake all to deposit and used later in one hour.Oral every day is more than three times, and (about 30 milliliters) at a gulp at every turn, buccal every day is more than six times, each (about 20 milliliters) flatly.Each about 10 minutes of buccal time; More than the every first quarter moon for the treatment of duration is a course for the treatment of.
Points for attention: for oral administration can produce constipation with (an about week) some people for a long time, need cut out up to constipation and stop.
The present invention with respect to the beneficial effect of prior art is: the present invention allocates white vinegar, Bulbus Allii juice, pure Mel, edible ethanol, cyclamate together, can play mutual supplement with each other's advantages, strengthen anti-inflammatory effect, reduce the medicine juice volatilization, in and tart flavour and acid, make it to become both oral administrations, the antibiotic medicine of multi-functional, the high curative effect that can be coated with again outward.Anti-inflammation drugs of the present invention also has the low characteristics of production cost, is easy to realize producing in batches.
The specific embodiment
Be described in further details below by the present invention of embodiment, these embodiment only are used for illustrating the present invention, do not limit the scope of the invention.
Embodiment 1 prepares anti-inflammation drugs of the present invention according to the following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) prepare following component in following mass fraction ratio: white vinegar 80%, Bulbus Allii juice 5%, pure Mel 10.55%, edible ethanol 4.4%, cyclamate 0.05%;
(3) add edible ethanol earlier in Bulbus Allii juice, stir, seal 1 hour, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(2) finish bottling after, 115 ℃ of high temperature steamings sterilization 1 hour.
Embodiment 2 prepares antiinflammatory treasured of the present invention according to the following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) prepare following component in following mass fraction ratio: white vinegar 67%, Bulbus Allii juice 11%, pure Mel 11.85%, edible ethanol 10%, cyclamate 0.15%;
(3) add edible ethanol earlier in Bulbus Allii juice, stir, seal 2 hours, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(4) finish bottling after, high temperature steaming sterilization more than 108 ℃ 1.5 hours.
Embodiment 3 prepares anti-inflammation drugs of the present invention according to the following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) prepare following component in following mass fraction ratio: white vinegar 78%, Bulbus Allii juice 8.8%, pure Mel 10%, edible ethanol 3%, cyclamate 0.15%;
(3) add edible ethanol earlier in Bulbus Allii juice, stir, seal 3 hours, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(4) finish bottling after, 110 ℃ of high temperature steamings sterilization 1.5 hours.
Embodiment 4 prepares anti-inflammation drugs of the present invention according to the following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) prepare following component in following mass fraction ratio: white vinegar 70%, Bulbus Allii juice 12%, pure Mel 11.4%, edible ethanol 6.5%, cyclamate 0.1%;
(3) add edible ethanol earlier in Bulbus Allii juice, stir, seal 5 hours, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(4) finish bottling after, 105 ℃ of high temperature steamings sterilization 2.5 hours.
Embodiment 5 prepares anti-inflammation drugs of the present invention according to the following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) prepare following component in following mass fraction ratio: white vinegar 60%, Bulbus Allii juice 15%, pure Mel 15%, edible ethanol 9.8%, cyclamate 0.2%;
(3) add edible ethanol earlier in Bulbus Allii juice, stir, seal 4 hours, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(4) finish bottling after, 100 ℃ of high temperature steamings sterilization 3 hours.
Embodiment 6 clinical treatment cases.In following clinical treatment case.When being used for the treatment for the treatment of for skin disease, be to be stained with full anti-inflammation drugs of the present invention with cotton balls or cotton stalk to spread upon the skin affected part, every day is more than six times; When being used for the treatment of digestive system and respiratory system disease, earlier by the ratio of anti-inflammation drugs of the present invention and pure water or cold boiled water 1:3, in anti-inflammation drugs adding pure water of the present invention or cold boiled water, shake all deposited one hour after, carrying out buccal or oral medication.Oral every day is more than three times, and (about 30 milliliters) at a gulp at every turn, buccal every day is more than six times, each (about 20 milliliters) flatly.Each about 10 minutes of buccal time; More than the every first quarter moon for the treatment of duration is a course for the treatment of.Concrete case is as follows:
1, Yuan Qinghong: diseases such as first future trouble eczema, beriberi, pharyngitis, chronic pharyngitis, stomatitis, gastroenteritis, flu were substantially all cured after using anti-inflammation drugs of the present invention in one to seven day.
2, contain fire: suffer from vulval eczema for many years, once antipruritic after using anti-inflammation drugs of the present invention, medication was cured in five days.
3, Li Qin: suffer from beriberi and can not be completely cured for many years, uses anti-inflammation drugs of the present invention after, once antipruritic, medication healing in seven days.
4, Li Hongcheng: suffer from chronic pharyngitis for many years, big infirmary has seen many times can not curing, and after containing pharynx anti-inflammation drugs of the present invention, one day takes effect, and cures in one month.
5, Yuan Xiaosong: suffered from stomatitis many days, uses anti-inflammation drugs of the present invention after, healing in three days.
6, Yang Yuanping: catch a cold, after using anti-inflammation drugs of the present invention, took effect the same day, cured in two days.
7, clock book: suffer from shank eczema, uses anti-inflammation drugs of the present invention after, recurrence is not seen in healing in five days more than a year.
8, Zhong Xiaozhen: suffer from dysentery, took anti-inflammation drugs of the present invention the same day after, cured the same day.
9, Xu Zhonghua: suffer from dermatitis, skin Pruritus many days after using anti-inflammation drugs of the present invention, once takes effect, and cures in three days.
The invention described above anti-inflammation drugs be applied to suffer from similar disease Lee so-and-so, Wei so-and-so etc. 128 people use, obvious curative effects is all arranged, the treatment effective percentage reaches 99.5%.

Claims (3)

1. an anti-inflammation drugs is characterized in that: composed of the following components: white vinegar, Bulbus Allii juice, pure Mel, edible ethanol, cyclamate.
2. anti-inflammation drugs according to claim 1, it is characterized in that: each mass fraction of forming component is: white vinegar 60-80%, Bulbus Allii juice 5-15%, pure Mel 10-15%, edible ethanol 3-10%, cyclamate 0.05-0.2%.
3. anti-inflammation drugs according to claim 1 and 2, it is characterized in that: its preparation method comprises following steps:
(1) selects high-quality Bulbus Allii meat to clean, squeeze the juice, make Bulbus Allii juice;
(2) press mass fraction: white vinegar 60-80%, the ratio of Bulbus Allii juice 5-15%, pure Mel 10-15%, edible ethanol 3-10%, cyclamate 0.05-0.2%, earlier in Bulbus Allii juice, add edible ethanol, stir, seal 1 ~ 4 hour, add white vinegar, pure Mel and cyclamate more successively, stir, the sealing twenty four hours filters then, bottles;
(3) set by step after (2) finish bottling, it was sterilized 1 ~ 2 hour at 100 ℃ ~ 200 ℃ high temperature steamings.
CN2013100334351A 2013-01-29 2013-01-29 Antiphlogistic drug Pending CN103202940A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013100334351A CN103202940A (en) 2013-01-29 2013-01-29 Antiphlogistic drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100334351A CN103202940A (en) 2013-01-29 2013-01-29 Antiphlogistic drug

Publications (1)

Publication Number Publication Date
CN103202940A true CN103202940A (en) 2013-07-17

Family

ID=48750494

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013100334351A Pending CN103202940A (en) 2013-01-29 2013-01-29 Antiphlogistic drug

Country Status (1)

Country Link
CN (1) CN103202940A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106540052A (en) * 2016-12-06 2017-03-29 郑州郑先医药科技有限公司 A kind of Western medicine combination for treating flu and preparation method thereof
CN112316098A (en) * 2020-12-02 2021-02-05 黄认训 A topical Chinese medicinal liquid for treating dermatoses
CN112516282A (en) * 2021-01-12 2021-03-19 史江华 Novel biological bactericide for hand and foot skin diseases and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1176125A (en) * 1997-09-10 1998-03-18 陈伟 Dressed antiphlogistic analgesic and its production process
CN101536781A (en) * 2009-03-31 2009-09-23 如皋市灵通酿造厂 Health-care drink and manufacture method
CN101756855A (en) * 2008-10-27 2010-06-30 吉祥 Garlic toner

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1176125A (en) * 1997-09-10 1998-03-18 陈伟 Dressed antiphlogistic analgesic and its production process
CN101756855A (en) * 2008-10-27 2010-06-30 吉祥 Garlic toner
CN101536781A (en) * 2009-03-31 2009-09-23 如皋市灵通酿造厂 Health-care drink and manufacture method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106540052A (en) * 2016-12-06 2017-03-29 郑州郑先医药科技有限公司 A kind of Western medicine combination for treating flu and preparation method thereof
CN112316098A (en) * 2020-12-02 2021-02-05 黄认训 A topical Chinese medicinal liquid for treating dermatoses
CN112516282A (en) * 2021-01-12 2021-03-19 史江华 Novel biological bactericide for hand and foot skin diseases and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104351450A (en) Citrus reticulata throat moistening creamy candy and preparing method thereof
CN104381557A (en) Making method of radix millettiae speciosae candy
CN105412858A (en) Syrup and preparation method thereof
CN102579655B (en) Externally applied traditional Chinese medicine preparation for treating oral ulcer
CN104258455B (en) A kind of medical bio antiseptic dressing and preparation method thereof
CN103202940A (en) Antiphlogistic drug
CN102727753B (en) Traditional Chinese medicine composition used for treating gout, and preparation method and application thereof
CN105285288A (en) Creamy candy assisting in treating pharyngolaryngitis and preparation method of creamy candy
CN104288736A (en) Tatarian aster root cough-relieving candy
CN101744871B (en) Propolis Chinese medicinal preparation for treating toothaches and preparation method thereof
CN101244117B (en) Chinese patent medicine preparation for treating piles and preparation method thereof
CN103446283A (en) Pharmaceutical composition for preventing and treating chemotherapy stomatitis
CN103585580B (en) A kind of Chinese medicine preparation for recurrent oral ulceration
CN113616721A (en) Pharmaceutical composition for treating oral ulcer and preparation method and application thereof
CN108721442B (en) Traditional Chinese medicine composition and preparation for treating burns, scalds and diaper dermatitis and preparation method thereof
CN102698202B (en) Chinese medicinal composition for treating gall-stone and preparation method and application of Chinese medicinal composition
CN112237604A (en) Traditional Chinese medicine incense for reducing epidemic infection and preparation process thereof
CN104800513A (en) Traditional Chinese medicine composition for treating cough variant asthma
CN104587034B (en) New application of a medicinal composition in treating oral ulcer
CN115252732B (en) Traditional Chinese medicine composition for clearing lung and relieving cough and application thereof
CN111358927B (en) Pujiang medicinal composition and application thereof
CN103705599B (en) A kind of pharmaceutical composition for the treatment of cough and preparation method thereof
CN115006466B (en) Traditional Chinese medicine preparation for treating eczema with damp-heat and yang deficiency and preparation method thereof
CN101607007B (en) Traditional Chinese medicine preparation for treating cerebral circulation insufficiency
CN105456708A (en) Drug for treating cheilitis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130717